Gritstone bio (GRTS)
(Delayed Data from NSDQ)
$0.66 USD
+0.01 (1.44%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $0.65 -0.01 (-1.04%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Balance Sheet
Fiscal Year End for Gritstone bio Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 82 | 176 | 213 | 171 | 128 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 6 | 7 | 8 | 4 | 4 |
Total Current Assets | 87 | 183 | 221 | 175 | 131 |
Net Property & Equipment | 17 | 21 | 22 | 22 | 27 |
Investments & Advances | 0 | 4 | 5 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 6 | 15 | 8 | 3 | 3 |
Total Assets | 178 | 241 | 278 | 222 | 184 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 4 | 9 | 4 | 10 | 5 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 14 | 16 | 11 | 8 | 7 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2 | 5 | 17 | 3 | 5 |
Total Current Liabilities | 27 | 35 | 40 | 27 | 20 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 3 | 8 | 10 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 40 | 19 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 126 | 70 | 62 | 55 | 50 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 711 | 692 | 618 | 493 | 355 |
Retained Earnings | -660 | -521 | -401 | -326 | -221 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 52 | 171 | 216 | 167 | 134 |
Total Liabilities & Shareholder's Equity | 178 | 241 | 278 | 222 | 184 |
Total Common Equity | 52 | 171 | 216 | 167 | 134 |
Shares Outstanding | 95.30 | 83.30 | 67.90 | 47.50 | 35.80 |
Book Value Per Share | 0.54 | 2.05 | 3.18 | 3.51 | 3.75 |
Fiscal Year End for Gritstone bio Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 48 | 82 | 85 | 117 |
Receivables | NA | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 4 | 6 | 6 | 5 |
Total Current Assets | NA | 52 | 87 | 91 | 122 |
Net Property & Equipment | NA | 14 | 17 | 19 | 20 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 6 | 6 | 7 | 8 |
Total Assets | NA | 137 | 178 | 187 | 223 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 7 | 4 | 4 | 5 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 11 | 14 | 12 | 10 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 1 | 2 | 1 | 3 |
Total Current Liabilities | NA | 26 | 27 | 23 | 22 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 40 | 40 | 30 | 30 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 1 | 1 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 123 | 126 | 113 | 113 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 714 | 711 | 703 | 700 |
Retained Earnings | NA | -700 | -660 | -629 | -590 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 14 | 52 | 74 | 110 |
Total Liabilities & Shareholder's Equity | NA | 137 | 178 | 187 | 223 |
Total Common Equity | 0 | 14 | 52 | 74 | 110 |
Shares Outstanding | 108.50 | 107.10 | 95.30 | 93.00 | 88.90 |
Book Value Per Share | 0.00 | 0.13 | 0.54 | 0.80 | 1.23 |